Rapport Therapeutics Inc (RAPP)

Dec 09, 2025

H.C. Wainwright raises Rapport Therapeutics stock price target to $40 on strong seizure drug data - Investing.com Canada

Dec 09, 2025

Dec 09, 2025

Rapport Therapeutics (NASDAQ:RAPP) Receives “Buy” Rating from BTIG Research - Defense World

Dec 09, 2025

Dec 08, 2025

Rapport Therapeutics, Inc. (RAPP) Is Up 9.03% in One Week: What You Should Know - Yahoo Finance

Dec 08, 2025

Dec 08, 2025

Rapport Therapeutics (NASDAQ:RAPP) Earns Buy Rating from BTIG Research - MarketBeat

Dec 08, 2025

Dec 08, 2025

BTIG Reiterates Rapport Therapeutics (RAPP) Buy Recommendation - Nasdaq

Dec 08, 2025

Dec 07, 2025

Rapport Therapeutics (RAPP) Valuation Check After a 60% Year-to-Date Share Price Surge - Yahoo Finance

Dec 07, 2025

Dec 06, 2025

RAP-219 Phase 2a Seizure Data and Planned Pivotal Trials Might Change The Case For Investing In Rapport Therapeutics (RAPP) - Yahoo Finance

Dec 06, 2025

Dec 06, 2025

Affinity Asset Advisors LLC Purchases Shares of 199,643 Rapport Therapeutics, Inc. $RAPP - Defense World

Dec 06, 2025

Dec 06, 2025

Wall Street Zen Downgrades Rapport Therapeutics (NASDAQ:RAPP) to Sell - Defense World

Dec 06, 2025

Dec 06, 2025

Rapport Therapeutics (NASDAQ:RAPP) Downgraded to Sell Rating by Wall Street Zen - Defense World

Dec 06, 2025

Dec 05, 2025

Rapport Therapeutics Announces Positive Phase 2a Post-Hoc Analysis of RAP-219 Demonstrating Early Efficacy in Drug-Resistant Focal Onset Seizures - Quiver Quantitative

Dec 05, 2025

Dec 05, 2025

Rapport Therapeutics Announces New Data and Post Hoc - GlobeNewswire

Dec 05, 2025

Dec 04, 2025

Will Rapport Therapeutics Inc. stock see PE expansionJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - Newser

Dec 04, 2025

Dec 04, 2025

Is Rapport Therapeutics Inc. stock trading at a premium valuationWeekly Market Report & Weekly High Conviction Trade Ideas - Newser

Dec 04, 2025

Dec 03, 2025

(RAPP) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Dec 03, 2025

Dec 01, 2025

Rapport Therapeutics (RAPP) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Dec 01, 2025

Rapport Therapeutics COO Cheryl Gault Sells 5,000 Shares - TradingView

Dec 01, 2025

Dec 01, 2025

Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Dec 01, 2025

Nov 28, 2025

Wall Street Analysts See a 74.99% Upside in Rapport Therapeutics, Inc. (RAPP): Can the Stock Really Move This High? - sharewise.com

Nov 28, 2025

Nov 28, 2025

Rapport Therapeutics (RAPP) Is Down 11.3% After Positive Phase 2a Data and $269M Offering – Has the Bull Case Changed? - Sahm

Nov 28, 2025

Nov 27, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Up 6.1%Here's What Happened - MarketBeat

Nov 27, 2025

Nov 26, 2025

A Look at Rapport Therapeutics’s Valuation as New RAP-219 Phase 2a Data Presentation Approaches - Sahm

Nov 26, 2025

Nov 25, 2025

How does Rapport Therapeutics Inc (RAPP) change from a tortoise to a hare? - Setenews

Nov 25, 2025

Nov 25, 2025

Could RAP-219’s Upcoming Data Reveal a Turning Point for Rapport Therapeutics’ Pipeline Strategy (RAPP)? - simplywall.st

Nov 25, 2025

Nov 25, 2025

Rapport Therapeutics to Present New Phase 2a Data Analysis - GlobeNewswire

Nov 25, 2025

Nov 23, 2025

What Analyst Ratings Reveal About Sagar Systech Limiteds Future ValueStock Buy Signals & Fast Growing Trading Plans - earlytimes.in

Nov 23, 2025

Nov 22, 2025

(RAPP) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Nov 22, 2025

Nov 20, 2025

Can Rapport Therapeutics Inc. stock outperform in 2025 bull marketStop Loss & Long-Term Growth Stock Strategies - newser.com

Nov 20, 2025

Nov 20, 2025

Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at BTIG Research - MarketBeat

Nov 20, 2025

Nov 19, 2025

Can trapped investors hope for a rebound in Rapport Therapeutics Inc. - newser.com

Nov 19, 2025

Nov 19, 2025

What institutional flow reveals about Rapport Therapeutics Inc.Weekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Rapport Therapeutics Inc. stock pay special dividendsJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025

Nov 19, 2025

This Extreme Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Nov 19, 2025

Nov 19, 2025

Analyzing Rapport Therapeutics Inc. with risk reward ratio chartsTreasury Yields & Safe Capital Growth Tips - newser.com

Nov 19, 2025

Nov 19, 2025

BTIG Research Initiates Coverage on Rapport Therapeutics With Buy Rating, $47 Price Target - MarketScreener

Nov 19, 2025

Nov 19, 2025

BTIG Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - Nasdaq

Nov 19, 2025

Nov 19, 2025

What candlestick patterns are forming on Rapport Therapeutics Inc.Gap Up & Verified Entry Point Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Why Rapport Therapeutics Inc. stock is a value investor pick2025 Technical Overview & Technical Pattern Based Signals - newser.com

Nov 19, 2025

Nov 18, 2025

Published on: 2025-11-18 22:13:16 - newser.com

Nov 18, 2025

Nov 18, 2025

Tools to monitor Rapport Therapeutics Inc. recovery probabilityMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com

Nov 18, 2025

Nov 18, 2025

Rapport Therapeutics Executives Sell Shares Under Trading Plans - TradingView

Nov 18, 2025

Nov 18, 2025

CEO Ceesay Sells 10,916 ($275K) Of Rapport Therapeutics Inc [RAPP] - TradingView

Nov 18, 2025

Nov 18, 2025

Rapport Therapeutics, Inc. (RAPP) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 18, 2025